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Abstract-Porous yttria-stabilized zirconia (YSZ) has been 
regarded as a potential candidate for bone substitute due to its 
high mechanical strength. However, porous YSZ is biologically 
inert to bone tissue. It is therefore necessary to introduce 
bioactive coatings onto the walls of the porous structures to 
enhance its bioactivity. In this study, porous YSZ scaffolds 
were prepared using a replication technique and then coated 
with mesoporous bioglass due to its excellent bioactivity. The 
microstructures were examined using scanning electron 
microscopy and the mechanical strength was evaluated via 
compression test. The biocompatibility and bioactivity were 
also evaluated using bone marrow stromal cell (BMSC) 
proliferation test and simulated body fluid test. 
Keywords: scaffold, porous structure, mesoporous bioglass, 
zirconia(YSZ), Compressive strength 
 
I.  INTRODUCTION 
For the filling and reconstruction of non-healing bone 
defects, the application of porous ceramic scaffold as bone 
substitutes is considered as a reasonable choice. The porous 
scaffold structure can aid cell migration and cell/gene 
delivery and provides a mechanical support to the newly 
formed tissue [1]. However, the mechanical properties of 
porous bioactive simplex ceramics are undesirable. Many 
studies to date have indicated that the compressive and 
bending strength of porous bioactive simplex ceramics are 
limited [2-5]. The porous ceramics such as the 
hydroxyapatite scaffold and the pure mesoporous bioglass 
scaffold have compressive strength of 1.75 MPa [6] and 60 
KPa [7], respectively. On the other hand, porous yttria-
stabilized zirconia (YSZ) is relatively strong and tough 
compared to other porous bioceramics, but has the problem 
of biological inertness to bone tissues. Therefore, many 
studies of zirconia based ceramics focused on combining the 
mechanical properties of zirconia with the bioactivity of 
other materials, such as hydroxyapatite coating. Up to now, 
however, there are few studies on mesoporous bioglass 
coating on porous zirconia. In this study, porous YSZ was 
prepared using a replication method and mesoporous 
bioglass (MBGs) was adopted as the coating material to 
improve its bioactivity. The structure-property relationship 
and the bioactivity were investigated. 
II. EXPERIMENT PROCEDURE 
A. Materials 
The materials used to prepare the porous bioceramics 
were 3 mol% yttria stabilized zirconia powder (Aldrich 
Chemical Company, Inc.) with an average particle size of 
0.265 μm and a specific surface area of 4.01 m2/g. Polyvinyl 
alcohol (PVA, SIGMA-ALDRICH, Inc.) solution containing 
97.5 wt.% water and 2.5 wt.% active substance was used as a 
binder for ceramic slurries. Sodium polymethacrylate 
(Richard E. Mistler, Inc.) solution was used as dispersant and 
HCl (0.1 M) and NaOH (0.1 M) were used to modify the pH 
of the slurries. The scaffold template was made from 
acrylonitrile butadiene styrene (ABS). 
B. Preparation of ABS scaffold templates 
ABS scaffold templates were firstly designed using 
Solidworks software and constructed using a 3D Rapid 
Prototyper, as shown in Fig. 1. The diameter of the rod in the 
template is 0.5 mm to obtain small channels in the final 
scaffold.  These regular mesopore-channels are expected to 
provide osteoinductivity and guide bone tissue growing well 
into the pores. As shown in Fig. 1, the template samples 
were designed in cubic and cylindrical shapes with different 
porosities and sample sizes. The detail of the template design 
is summarized in Tab. 1. 
 
 
 
Figure 1: Template design (A and C) and rapidly prototyped samples 
using a 3D printer  
 Table 1: Parameters of the cube and cylinder ABS scaffold templates 
 
Parameters 
 
 
 
Shapes 
Strut Spacing 
(mm) 
Top Area 
(mm
2
) 
Height 
(mm) 
Cube 
1 9×9 
10 
1 11×11 
1 13×13 
 
2.5 9×9 
2.5 11×11 
2.5 13×13 
 
Cylinder 
1 π×(9/2)2 
1 π×(11/2)2 
1 π×(13/2)2 
 
2.5 π×(9/2)2 
2.5 π×(11/2)2 
2.5 π×(13/2)2 
C. Preparation of porous scaffolds 
3 mol% yttria stabilized zirconia powders were mixed 
with 1 wt.% PVA, 2 wt.% sodium polymethacrylate, and 
appropriate distilled water to form zirconia slurry. The ABS 
templates were coated with wax to reduce possible thermal 
expansion during the sintering process. Zirconia slurry was 
infiltrated into the templates to obtain the porous structures. 
After drying in air for two days for pyrolysis of the organic 
phases, the sintering was carried out at 1400°C for 2 hours [3, 
7-8]. A slow heating rate of 1 °C/min was used up to 700°C 
to burn out the ABS and minimize the cracking due to 
thermal expansion. Then, 5°C/min heating rate was used to 
1400°C [8] to form the porous scaffolds. 
D. Preparation of mesoporous bioglass (MBGs)cating  
The MBGs (SiO2–CaO–P2O5) sols were prepared 
following the method reported by Pereira et al. [9] and Zhu 
et al. [10]. In this study, 6g of Pluronic® F-127 (Sigma-
Aldrich) and 8.9g of tetraethyl orthosilicate (TEOS, 98%, 
Sigma-Aldrich) were added to 65g of 98% ethanol and 
stirred till the solution became clear. Then, 5g of 1mol/L 
hydrochloric acid (HCL) was added with mixing for 15 
minutes. Finally, 1.89g of calcium nitrate 
(Ca(NO3)24H2O, >99.0%, Sigma-Aldrich) and 0.73g triethyl 
phosphate (TEP, 99.8%, Sigma–Aldrich) were added and 
mixed for 45 min. The obtained mixture was stirred at 30°C 
for 24 hours. The molar ratio of SiO2: CaO: P2O5 was 
80:16:4. 
A dip-coating process was used for coating the MBGs. 
The porous zirconia samples were immersed into the MBGs 
sol-gel solution for 2 min. The samples were then 
centrifuged under 500 rpm for 30 seconds to remove the 
extra sols. After drying for one day in air at room 
temperature, the coated porous zirconia was sintered at 
1200°C for 2 hours. Then, the process was repeated for the 
second coating but the temperature was controlled at 700°C 
for 3 hours. The heating rate was 5°C/min for sintering the 
two coatings.  
E. Characterization 
1) Porosity of the porous zirconia ceramic. 
The porosity of a scaffold was determined by measuring 
the dimensions and the mass of the scaffold and calculated 
using the following formula: 
 
     
 
           
      ........................ (1) 
 
where P is the porosity, m is the mass of the scaffold, ρ is 
the true density of the zirconia and V is the volume of the 
scaffold. 
 
2) Mechanical testing 
 Compression test was conducted to evaluate the mechanical 
strength and its dependence with sample size, sample shape 
and porosity. The test was conducted using a Hounsfield 
testing machine at a loading rate of 0.5mm/min. 
 
3) In-vitro biocompatibility test 
To evaluate bone marrow stromal cell (BMSC) 
proliferation, BMSCs were seeded on biomaterial disks in 
24-well plate at a density of 5×103 cells/well and incubated 
for 4 h. 20 mg of zirconia scaffold specimens were added to 
the culture plate. Cells were then incubated at 37ºC in 5% 
CO2 for 7 days. Then, 40 μL of 0.5 mg/mL MTT (3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide) 
solution (Sigma, Aldrich) was added in each well and 
incubated for 4 h at 37ºC. The reaction was terminated by 
the addition of 100 μL dimethyl sulfoxide. The absorbance 
of the formazan was read at 495 nm using an Enzyme-
linked immunosorbent assay (ELISA) plate reader (Bio-Rad 
Laboratories, Pty., Ltd, Gladesville, New South Wales, 
Australia). The MTT assay is to assess cell viability and 
grow based upon the conversion of MTT to formazan. 
Results were expressed as absorbance reading from each 
well minus the optical density (OD) value of blank wells. 
For comparison, BMSC proliferation without the addition of 
specimens and zirconia scaffold without adding cells were 
also evaluated by the same procedure. 
 
4) In-vitro bioactivity test 
It is believed that simulated body fluid (SBF) is useful 
for prediction of the in-vivo bone bioactivity of a given 
material [11-12]. To this end, the scaffolds prepared were 
separated into three groups. The uncoated scaffolds (Group 
1) were immersed into the simulated body fluid (SBF) for 7 
days at 37°C. The scaffolds coated with the bioglass were 
immersed into the SBF for 4 days (Group 2) and 7 days 
(Group 3) at 37°C. 
 
5) Scanning electron Microscopy (SEM) 
The scaffolds were coated with gold using a sputter 
coater (BioRad SC500). Then, the microstructure of the 
mesoporous bioglass coating and the scaffolds were 
examined using a scanning electron microscope (FEI 
QUANTA 200) with the acceleration voltage of 15 kV and 
25 kV. 
III. RESULTS AND DISCUSSION 
A. Porosity and shrinkage of uncoated zirconia scaffolds 
Fig. 2 shows the sectional view of uncoated zirconia 
scaffold. The size of the big channel is about 0.5~0.8mm.  
Small pores can be observed in the scaffolds, Fig. 2 (b). 
However, there still have some small cracks between pores. 
Tiny cracks can be also observed. It is due to the difference 
in the thermal expansion coefficient between the ABS 
template and zirconia. 
 
  
FIGURE 2: SEM micrographs of the uncoated scaffolds with low 
magnified (A) and high magnified (B). 
 
Based on Equation 1, the dimensional change after the 
sintering can be measured to evaluate the shrinkage rate. The 
shrinkage rate and porosity estimated are 19.14~29.59%, and 
63~68±2.5%, respectively. 
 
B. Mechanical properties of uncoated and coated scaffolds 
1) Effect of scaffold size and shape on compressive 
strength 
Compressive strength and its dependence with sample 
size, sample shape and porosity were evaluated. Fig. 3 
shows the variation of compressive strength with the sample 
end surface area for the scaffolds with cubic and cylindrical 
shapes. It is clear that the compressive strength decreases 
with the end surface area. This is because the material 
volume is proportional to the end surface area. The higher 
the volume, the higher the density of defects the scaffold has.  
In addition, the scaffolds with a cylinder shape have a 
higher strength than those with a cubic shape. The reason 
may be attributed to a reduced surface area and less possible 
stress concentration in the cylindrical samples. As expected, 
a higher strength can be observed in the coated samples, 
indicating the healing effects of coating on small defects 
such as tiny cracks. 
 
2) Effect of porosity on compressive strength 
The variation of compressive strengths with porosity in 
the scaffolds with different template design (strut spacing) is 
shown in Fig. 4. The compressive strength decreases with the 
porosity. Although there is significant data scatter, the 
general trend is in agreement with the investigation by others 
[7, 13]. 
 
 
FIGURE 3: Compressive strength versus specimen size 
 
 
FIGURE 4: Compressive strength versus porosity for porous zirconia 
scaffolds with two series of strut spacing. 
 
 
FIGURE 5: Compressive strength of for uncoated and two-layer coated 
scaffolds. 
 
3) Effect of MBGs coating on compressive strength 
It has been observed that the strength increase in the one-
layer coated scaffold is very limited. On the other hand, Fig. 
5 shows the compressive strength in the scaffolds with two-
layer coatings. It is clear that a higher compressive strength 
is associated with all coated samples tested. In other words, 
two-layer MBGs coating is more efficient than one layer 
coating in increasing mechanical strength. The possible 
reason is further reduction of tiny defects such as cracks after 
repeated coatings.  
 
C. BMSC Proliferation test and MTT assay 
Fig. 6 shows the SEM images of BMSC proliferation test. 
It seems that both uncoated and coated zirconia scaffolds 
have good biocompatibility. The bone marrow stromal cells 
were migrating, attaching and proliferating well on the pore 
walls but not on other areas because the pore curvature could 
provides optimum compression and tension on the cell’s 
mechanoreceptors [14].  
Fig. 7 shows the average optical density (OD) value of 
uncoated and MBGs coated zirconia scaffolds at day 1, day 3, 
and day 6. The OD value slightly increases after 6 days, and 
there was a slight increase of the OD value in the coated 
scaffold. Therefore, both uncoated and coated scaffolds have 
good cell viability without obvious cytotoxicity. 
 
 
FIGURE 6: SEM images of uncoated (A) and MBGs coated (B) scaffolds 
 
 
FIGURE 7: The average OD value of uncoated and MBGs coated zirconia 
scaffold at day 1, 3, and 6. 
 
D. Simulated Body Fluid (SBF) Test 
The bioactivity of MBGs coated zirconia scaffolds were 
evaluated in SBF. There was nothing changed on the surface 
of the uncoated zirconia scaffolds (group 1) after immersing 
into the SBF for 7 days at 37°C. The scaffolds in group 2 
and group 3 were coated with mesoporous bioglass and 
immersed into the SBF for 4 days and 7 days, respectively.  
In Fig.8 shows the SEM images of the mesoporous 
bioglass coating after the SBF test. The coating layer has 
average thickness of 7 μm. The formation of apatite was not 
observed on the wall surfaces in group 2. On the other hand, 
some hoarfrost was formed on the coating layers in the 
samples of the group 3. Compared to the work of Kokubo et 
al [11], the apatite is believed to form on the coatings. As 
shown in Fig. 9, the compositional analysis indicates a high 
concentration of Si and Ca on the coating in the group 3 
(7days). The high Ca is believed to be caused by the 
precipitation of Ca from SBF solution, indicating a high 
possibility of forming apatite. However, not much Ca could 
be observed in the group 2. It means the significant bioactive 
can be observed after 7 days SBF testing. Therefore, it can 
be concluded that the coated porous zirconia has high 
bioactivity. 
 
 
  
 
FIGURE 8: SEM images of MBGs coated scaffolds in SBF after 4 days (A) 
and 7days (B) at 37°C. 
 
FIGURE 9: Compositional analysis of coating surface in group 3 
 
IV. CONCLUSION 
Porous zirconia scaffold structures had high porosities of 
63±2.8% to 68±2.5% with shrinkage rates of 19.14% ~ 
29.59%. Most macropores were interconnected with pore 
sizes of 0.5~0.8mm. The compressive strength of the porous 
zirconia decreased with the increase of specimen size and the 
porosity. The uncoated cube and cylinder porous zirconia 
scaffolds respectively showed The compressive strength of 
the uncoated scaffolds with cubic and cylindrical shapes was 
in the range of 18.95~46.76 MPa and 38.24~110.51 MPa. A 
higher compressive strength was observed in the bioglass 
coated scaffolds, i.e., 34.22~55.01 MPa and 44.35~ 123.32 
MPa, respectively in the ones with cubic and cylindrical 
shapes. Repeated coatings could further increase the 
mechanical strength.   
The BMSC proliferation test and MTT assay results 
demonstrated that both uncoated and MBGs coated zirconia 
scaffolds have good biocompatibility and cell viability 
without obvious cytotoxicity. After the simulated body fluid 
(SBF) testing for 7 days, apatite was formed on the coating 
surface, indicating good bioactivity.  
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